Sponsors (2)
Official title: Require the Secretary of Health and Human Services, acting through the Assistant Secretary for Preparedness and Response, to carry out a program under which the Secretary requires each covered distributor of a highly pathogenic agent to comply with certain logbook requirements, and for other purposes.
Introduced March 26, 2026 by Catherine Marie Cortez Masto · Last progress March 26, 2026
The bill strengthens federal tracking, coordination, and safety standards for high‑risk biological agents—boosting outbreak response and lab safety—but does so at the cost of new administrative burdens, compliance expenses, and potential privacy/security risks for researchers, labs, distributors, and taxpayers.
Researchers, public health authorities, and hospitals get centralized access to transfer records and (potential) facility data, improving traceability of high‑risk agents and speeding outbreak response and investigations.
BSL‑3+ laboratories and their communities benefit from periodic strategic evaluations and national safety/security standards, reducing the risk of lab accidents or misuse.
State, local, Tribal, and territorial health officials receive a single Federal point of contact for biosafety and biosecurity issues, improving coordination and response speed during incidents.
Researchers, university and hospital labs, and distributors must collect, store, and report much more detailed purchaser and transaction data, creating ongoing administrative burdens and compliance costs that could strain small labs and raise costs for research.
Logbooks and any public listing or centralized database of facilities/transfers contain sensitive information that, if accessed or released improperly, could be targeted or misused by malicious actors, increasing biosecurity and privacy risks for labs and communities.
Requirements for government‑grade photo ID, identity verification, and criminal penalties for false statements may deter legitimate buyers or complicate routine transfers for small repositories and labs.
Based on analysis of 3 sections of legislative text.
Requires electronic transaction logbooks for transfers of defined highly pathogenic agents and creates federal oversight and strategic evaluations of high-containment laboratories.
Creates a federal program requiring distributors who sell or transfer defined “highly pathogenic agents” to keep an electronic logbook recording purchaser identity, intended use, storage location, and transaction details; the Department of Health and Human Services must create and annually update the list of covered agents and specify logbook standards. Directs the National Security Advisor to pick one federal entity to conduct strategic evaluations of high-containment laboratories nationwide, develop up-to-date national standards for their design and operation, create a public liaison team for state/local/tribal partners, and study the feasibility of a searchable database of high-containment labs.